Bellevue Life Sciences Ac... (BLAC)

AI Score

Unlock

3.01

-3.72 (-55.27%)

At close: Feb 14, 2025, 3:53 PM

2.81

-6.75%

After-hours: Feb 14, 2025, 07:59 PM EST

Bellevue Life Sciences Acquisition Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-454.13K	-475.54K	-450.78K	-861.89K	-410.43K	-280.27K	-278.1K	-35.39K	-20.02K	-988	-126	-320	-120	-2.74K	-124
Interest Income	269.2K	465.5K	480.82K	928.76K	618.5K	810.3K	417.73K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-184.93K	-10.04K	30.04K	66.87K	208.07K	530.03K	139.63K	-14.25K	-20.02K	-988	-126	-322	-119	-2.74K	-124
Net Income	-230.96K	-97.3K	-60.43K	-86.17K	78.18K	301.46K	110.31K	-14.25K	-20.02K	-988	-126	-322	-119	-2.74K	-124
Selling & General & Admin	454.13K	475.54K	450.78K	861.89K	410.43K	280.27K	278.1K	14.25K	20.02K	988.00	126.00	322.00	119.00	2.74K	124.00
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	454.13K	475.54K	450.78K	861.89K	410.43K	280.27K	278.1K	14.25K	20.02K	988.00	126.00	322.00	119.00	2.74K	124.00
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	454.13K	475.54K	450.78K	861.89K	410.43K	280.27K	278.1K	14.25K	20.02K	988.00	126.00	322.00	119.00	2.74K	124.00
Income Tax Expense	46.03K	87.26K	90.47K	153.04K	129.88K	228.56K	29.32K	-33.74K	-27.08K	-86.06K	-60.45K	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	4.04M	4.04M	5.62M	7.41M	9.05M	9.05M	5.23M	9.05M	7.93M	7.93M	7.93M	7.89M	7.93M	7.89M	7.89M
Shares Outstanding (Diluted)	4.04M	4.04M	5.62M	7.41M	9.05M	9.05M	5.23M	9.05M	7.93M	7.93M	7.93M	7.89M	7.93M	7.89M	7.89M
EPS (Basic)	-0.06	-0.02	-0.01	-0.01	0.01	0.03	0.02	-0.00	-0.00	-0.00	n/a	n/a	n/a	-0.00	n/a
EPS (Diluted)	-0.06	-0.02	-0.01	-0.01	0.01	0.03	0.02	-0.00	-0.00	-0.00	n/a	n/a	n/a	-0.00	n/a
EBITDA	-454.13K	-475.54K	-450.78K	-861.89K	-410.43K	-280.27K	-278.1K	-14.25K	-20.02K	-988	-126	-322	-119	-2.74K	-124
EBIT	-454.13K	-475.54K	-450.78K	-861.89K	-410.43K	-280.27K	-278.1K	-14.25K	-20.02K	-988	-126	-322	-119	-2.74K	-124
Depreciation & Amortization	n/a	n/a	43.28K	43.81K	-39.59K	122.08K	41.58K	21.14K	27.08K	86.06K	60.46K	n/a	n/a	n/a	n/a